These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9868964)

  • 1. Two cases of myelodysplastic syndrome with extramedullary polyclonal plasma cell proliferation and autoantibody production: possible role of soluble Fas antigen for production of excessive self-reactive B cells.
    Katsuki K; Shinohara K; Kameda N; Yamada T; Takeda K; Kamei T
    Intern Med; 1998 Nov; 37(11):973-7. PubMed ID: 9868964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of myelodysplastic syndrome and multiple myeloma.
    Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohematological findings in myelodysplastic syndrome.
    Novaretti MC; Sopelete CR; Velloso ER; Rosa MF; Dorlhiac-Llacer PE; Chamone DA
    Acta Haematol; 2001; 105(1):1-6. PubMed ID: 11340246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M; Yamauchi H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between autoantibody and dermatosis in myelodysplastic syndrome.
    Shimamoto Y; Narisawa Y; Suga K; Yasutake T; Kohda H; Yamaguchi M
    Haematologia (Budap); 1993; 25(4):253-61. PubMed ID: 8157207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific cutaneous lesion revealing myelodysplastic syndrome.
    Kajisawa C; Matsui C; Morohashi M
    Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration of extramedullary myeloid cell tumor in myelodysplastic syndrome. A report of three cases.
    Gujral S; Kumar R; Jain P; Sharma A; Gupta S; Kumar L; Raina V; Kochupillai V
    Acta Cytol; 1999; 43(4):647-51. PubMed ID: 10432889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy.
    Silverman LR; Greenberg P; Raza A; Olnes MJ; Holland JF; Reddy P; Maniar M; Wilhelm F
    Hematol Oncol; 2015 Jun; 33(2):57-66. PubMed ID: 24777753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of immunophenotypic features of blasts in patients with myelodysplastic syndrome by flow cytometry and its diagnostic significance].
    Sun JF; Yang B; Zhang L; Huang Y; Yang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):632-5. PubMed ID: 22739171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
    Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas/APO-1 (CD95) expression in myelodysplastic syndromes.
    Lepelley P; Grardel N; Erny O; Iaru T; Obein V; Cosson A; Fenaux P
    Leuk Lymphoma; 1998 Jul; 30(3-4):307-12. PubMed ID: 9713962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.